|
1
|
Libby P, Ridker PM and Hansson GK:
Inflammation in atherosclerosis: from pathophysiology to practice.
J Am Coll Cardiol. 54:2129–2138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galkina E and Ley K: Immune and
inflammatory mechanisms of atherosclerosis. Annu Rev Immunol.
27:165–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krupinski J, Font A, Luque A, Turu M and
Slevin M: Angiogenesis and inflammation in carotid atherosclerosis.
Front Biosci. 13:6472–6482. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tahara N, Imaizumi T, Virmani R and Narula
J: Clinical feasibility of molecular imaging of plaque inflammation
in atherosclerosis. J Nucl Med. 50:331–334. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Williams KJ and Tabas I: The
response-to-retention hypothesis of early atherogenesis.
Arterioscler Thromb Vasc Biol. 15:551–561. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ylä-Herttuala S, Solakivi T, Hirvonen J,
et al: Glycosaminoglycans and apolipoproteins B and A-I in human
aortas: chemical and immunological analysis of lesion-free aortas
from children and adults. Arteriosclerosis. 7:333–340.
1987.PubMed/NCBI
|
|
7
|
Steinberg D, Parthasarathy S, Carew TE, et
al: Beyond cholesterol. Modifications of low-density lipoprotein
that increase its atherogenicity. N Engl J Med. 320:915–924.
1989.PubMed/NCBI
|
|
8
|
Li AC and Glass CK: The macrophage foam
cell as a target for therapeutic intervention. Nat Med.
8:1235–1242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pennant M, Davenport C, Bayliss S,
Greenheld W, Marshall T and Hyde C: Community programs for the
prevention of cardiovascular disease: a systematic review. Am J
Epidemiol. 172:501–516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bash LD, Erlinger TP, Coresh J,
Marsh-Manzi J, Folsom AR and Astor BC: Inflammation, hemostasis,
and the risk of kidney function decline in the Atherosclerosis Risk
in Communities (ARIC) Study. Am J Kidney Dis. 53:596–605. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sherer Y, Zinger H and Shoenfeld Y:
Atherosclerosis in systemic lupus erythematosus. Autoimmunity.
43:98–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Doria A: Atherosclerosis and lupus: what
we know and what we should know. J Rheumatol. 36:2380–2382. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ylä-Herttuala S, Rosenfeld ME,
Parthasarathy S, et al: Gene expression in macrophage-rich human
atherosclerotic lesions: 15-lipoxygenase and acetyl low density
lipoprotein receptor messenger RNA colocalize with oxidation
specific lipid-protein adducts. J Clin Invest. 87:1146–1152.
1991.
|
|
14
|
Kunjathoor VV, Febbraio M, Podrez EA, et
al: Scavenger receptors class A-I/II and CD36 are the principal
receptors responsible for the uptake of modified low density
lipoprotein leading to lipid loading in macrophages. J Biol Chem.
277:49982–49988. 2002. View Article : Google Scholar
|
|
15
|
Suzuki H, Kurihara Y, Takeya M, et al: A
role for macrophage scavenger receptors in atherosclerosis and
susceptibility to infection. Nature. 386:292–296. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shibata N and Glass CK: Regulation of
macrophage function in inflammation and atherosclerosis. J Lipid
Res. 50:S277–S281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gallo LL, Atasoy R, Vahouny GV and
Treadwell CR: Enzymatic assay for cholesterol ester hydrolase
activity. J Lipid Res. 19:913–916. 1978.PubMed/NCBI
|
|
18
|
Gamble W, Vaughan M, Kruth HS and Avigan
J: Procedure for determination of free and total cholesterol in
micro- or nanogram amounts suitable for studies with cultured
cells. J Lipid Res. 19:1068–1070. 1978.PubMed/NCBI
|
|
19
|
Saha P, Modarai B, Humphries J, Mattock K,
Waltham M, Burnand KG and Smith A: The monocyte/macrophage as a
therapeutic target in atherosclerosis. Curr Opin Pharmacol.
9:109–118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jozefowski S, Arredouani M, Sulahian T and
Kobzik L: Disparate regulation and function of the class A
scavenger receptors SR-AI/II and MARCO. J Immunol. 175:8032–8041.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Neyen C, Plüddemann A, Roversi P, Thomas
B, Cai L, van der Westhuyzen DR, Sim RB and Gordon S: Macrophage
scavenger receptor A mediates adhesion to apolipoproteins A-I and
E. Biochemistry. 48:11858–11871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Greaves DR and Gordon S: The macrophage
scavenger receptor at 30 years of age: current knowledge and future
challenges. J Lipid Res. 50:S282–S286. 2009.PubMed/NCBI
|
|
23
|
Osto E, Kouroedov A, Mocharla P, Akhmedov
A, Besler C, Rohrer L, von Eckardstein A, Iliceto S, Volpe M,
Lüscher TF and Cosentino F: Inhibition of protein kinase Cbeta
prevents foam cell formation by reducing scavenger receptor A
expression in human macrophages. Circulation. 118:2174–2182. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Plüddemann A, Neyen C and Gordon S:
Macrophage scavenger receptors and host-derived ligands. Methods.
43:207–217. 2007.
|
|
25
|
Van Berkel TJ, Van Eck M, Herijgers N,
Fluiter K and Nion S: Scavenger receptor classes A and B: their
roles in atherogenesis and the metabolism of modified LDL and HDL.
Ann NY Acad Sci. 902:113–126. 2000.PubMed/NCBI
|
|
26
|
Li K, Yao W, Zheng X and Liao K: Berberine
promotes the development of atherosclerosis and foam cell formation
by inducing scavenger receptor A expression in macrophage. Cell
Res. 19:1006–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moore KJ and Freeman MW: Scavenger
receptors in atherosclerosis: beyond lipid uptake. Arterioscler
Thromb Vasc Biol. 26:1702–1711. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goldstein JL and Brown MS: The LDL
receptor. Arterioscler Thromb Vasc Biol. 29:431–438. 2009.
View Article : Google Scholar
|
|
29
|
Mazière C and Mazière JC: Activation of
transcription factors and gene expression by oxidized low-density
lipoprotein. Free Radic Biol Med. 46:127–137. 2009.PubMed/NCBI
|
|
30
|
Issandou M: Pharmacological regulation of
low density lipoprotein receptor expression: current status and
future developments. Pharmacol Ther. 111:424–433. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vainio S and Ikonen E: Macrophage
cholesterol transport: a critical player in foam cell formation.
Ann Med. 35:146–155. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sato R: Sterol metabolism and SREBP
activation. Arch Biochem Biophys. 501:177–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Osborne TF and Espenshade PJ: Evolutionary
conservation and adaptation in the mechanism that regulates SREBP
action: what a long, strange tRIP it’s been. Genes Dev.
23:2578–2591. 2009.PubMed/NCBI
|
|
34
|
Bengoechea-Alonso MT and Ericsson J: SREBP
in signal transduction: cholesterol metabolism and beyond. Curr
Opin Cell Biol. 19:215–222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shimano H: SREBPs: physiology and
pathophysiology of the SREBP family. FEBS J. 276:616–621. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu J, Zhang F, Li C, Lin M and Briggs MR:
Synergistic activation of human LDL receptor expression by SCAP
ligand and cytokine oncostatin M. Arterioscler Thromb Vasc Biol.
23:90–96. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gierens H, Nauck M, Roth M, Schinker R,
Schürmann C, Scharnagl H, Neuhaus G, Wieland H and März W:
Interleukin-6 stimulates LDL receptor gene expression via
activation of sterol-responsive and Sp1 binding elements.
Arterioscler Thromb Vasc Biol. 20:1777–1783. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hansson GK: Inflammatory mechanisms in
atherosclerosis. J Thromb Haemost. 7(Suppl 1): 328–331. 2009.
View Article : Google Scholar
|
|
39
|
Ye Q, Chen Y, Lei H, Liu Q, Moorhead JF,
Varghese Z and Ruan XZ: Inflammatory stress increases unmodified
LDL uptake via LDL receptor: an alternative pathway for macrophage
foam-cell formation. Inflamm Res. 58:809–818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Y, Ruan XZ, Li Q, et al: Inflammatory
cytokines disrupt LDL-receptor feedback regulation and cause statin
resistance: a comparative study in human hepatic cells and
mesangial cell. Am J Physiol Renal Physiol. 293:F680–F687. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ruan XZ, Moorhead JF, Fernando R, Wheeler
DC, Powis SH and Varghese Z: Mechanisms of dysregulation of
low-density lipoprotein receptor expression in vascular smooth
muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc
Biol. 26:1150–1155. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ruan XZ, Varghese Z, Powis SH and Moorhead
JF: Dysregulation of LDL receptor under the influence of
inflammatory cytokines: a new pathway for foam cell formation.
Kidney Int. 60:1716–1725. 2001. View Article : Google Scholar : PubMed/NCBI
|
